The Liverpool Centre for Cardiovascular Science, an alliance between academia and the NHS, was established to advance cardiovascular and stroke research and innovation locally, nationally, and internationally. The director of the centre, Professor Gregory YH Lip, Price-Evans chair of cardiovascular medicine at the University of Liverpool and CVD programme director for Liverpool Health Partners, explains the concept.
Liverpool is a disadvantaged city, with high levels of cardiovascular disease (CVD) that are a leading cause of death and disability and associated health inequalities. The mission statement of the recently established Liverpool Centre for Cardiovascular Science is to support the citizens of the Liverpool City region to live healthier lives, free of cardiovascular diseases and stroke. The vision is that by 2024 implementation of this strategy will have contributed directly to improved cardiovascular health and reduced premature death from cardiovascular diseases and stroke.
Officially launched in September 2018 at Liverpool Town Hall on the eve of World Heart Day, the centre brings together experts from academic institutions and NHS partners at the University of Liverpool, Liverpool Heart and Chest Hospital, Liverpool John Moores University, and Liverpool Health Partners, to work for the advancement of cardiovascular and stroke research. This exciting collaboration has assembled a multidisciplinary group of NHS and academic (clinical and non-clinical) researchers in a cross-university, cross-departmental partnership to develop research without boundaries. The Liverpool Heart and Chest Hospital hosts the clinical base of the Liverpool Centre for Cardiovascular Science, providing the academic department with the opportunity for high quality cardiovascular research in newly refurbished facilities.
Atrial fibrillation will be one of the primary research areas of the centre, given the major interest and research into this disease area. Other fields of interest include hypertension, thrombosis and antithrombotic therapy, imaging, and clinical epidemiology.
The centre will become part of a global network of cardiovascular research, working particularly closely with Aalborg University in Denmark (with which I am also affiliated in my role as a Distinguished Professor), and numerous other formal academic partners in Serbia, China, Japan, Taiwan, Korea, Thailand, Sri Lanka, and Brazil.
Given the broad spectrum of research interests, the Liverpool Centre for Cardiovascular Science aspires to make a major impact in cardiovascular research and innovation, in order to improve our understanding of the disease and the clinical care of patients, with the goal of reducing the healthcare burden at a local, national, and international level.